<?xml version="1.0" encoding="UTF-8" ?><!-- Generated on Fri, 01 May 2026 23:21:00 -0400--><rss version="2.0">
    <channel>
        <title>Benitec Biopharma Inc. (BNTC) Media Coverage</title>
        <link>https://www.benitec.com/for-investors/news-events/media-coverage/rss</link>
        <description></description>
        <language>en-us</language>
                                            <image>
                <url>https://d1io3yog0oux5.cloudfront.net/_2ac9ccf12c80722bb5d415d65f14b333/benitec/files/theme/images/logo-sm.png</url>
                <title>Benitec Biopharma Inc. Logo</title>
                <link>/for-investors</link>
            </image>
                <generator>Equisolve Investor Relations Suite</generator>
        
                            <item>
                <title><![CDATA[Benitec Biopharma receives Russian regulatory approval for oncology study]]></title>
                <description><![CDATA[]]></description>
                <link>https://smallcaps.com.au/benitec-biopharma-russian-regulatory-approval-oncology-study/</link>
                <pubDate>Fri, 25 May 18 00:00:00 -0400</pubDate>
                <guid>https://smallcaps.com.au/benitec-biopharma-russian-regulatory-approval-oncology-study/</guid>
                                                                            </item>
                    <item>
                <title><![CDATA[Drug Development Technology: Benitec starts Phase II trial of BB-401 for HNSCC]]></title>
                <description><![CDATA[]]></description>
                <link>https://www.drugdevelopment-technology.com/news/benitec-starts-phase-ii-trial-bb-401-hnscc/</link>
                <pubDate>Fri, 09 Mar 18 00:00:00 -0500</pubDate>
                <guid>https://www.drugdevelopment-technology.com/news/benitec-starts-phase-ii-trial-bb-401-hnscc/</guid>
                                                                            </item>
                    <item>
                <title><![CDATA[Muscular Dystrophy News Today: Benitec Seeks Regulatory Approval to Advance BB-301 into Clinical Trials]]></title>
                <description><![CDATA[]]></description>
                <link>https://musculardystrophynews.com/2017/11/29/benitec-seeks-regulatory-approval-to-advance-bb-301-for-opmd-into-clinical-trials/</link>
                <pubDate>Thu, 30 Nov 17 00:00:00 -0500</pubDate>
                <guid>https://musculardystrophynews.com/2017/11/29/benitec-seeks-regulatory-approval-to-advance-bb-301-for-opmd-into-clinical-trials/</guid>
                                                                            </item>
            </channel>
</rss>